William van Wyck
Internal Medicine · Ocean Gate, NJNPI 1629184205
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $792 and has fallen 98.1% since, to $15 in 2023.
Across 121 payments — averaging $13.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$335
- Johnson & Johnson$274
- AstraZeneca$229
- Merck$105
- Kowa Pharmaceuticals America, Inc.$98
- Lilly USA, LLC$90
- plus $465 from 11 others
What the payments were for
- Food & beverage$1,596100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 29 | $335 |
| Johnson & Johnson | 20 | $274 |
| AstraZeneca | 17 | $229 |
| Merck | 8 | $105 |
| Kowa Pharmaceuticals America, Inc. | 7 | $98 |
| Lilly USA, LLC | 6 | $90 |
| Astellas Pharma US Inc | 6 | $84 |
| Amarin Pharma, Inc. | 5 | $74 |
| Novo Nordisk | 4 | $54 |
| AbbVie | 4 | $52 |
| GSK | 3 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $35 |
| Boehringer Ingelheim | 2 | $30 |
| Amgen | 2 | $29 |
| Indivior Inc. | 2 | $28 |
| Novartis | 2 | $23 |
| Shire North American Group Inc | 1 | $15 |
How this compares
$1,596 in reported general payments places this provider in the 70th percentile of 4,032 internal medicine providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 21 | $191 |
| Metformin Hcl | 13 | $169 |
| Amlodipine Besylate | 16 | $130 |
| Lisinopril | 14 | $106 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Ocean Gate
- David ShulkinMorristown$1.7M
- Howard UdermanLakewood$955K
- Darshi SunderamEast Orange$530K
- Annika DrongeEmerson$401K
- Stephen MarcellaNew Brunswick$331K
- Viju VijaysadanKinnelon$325K
- Mark MonaneWoodcliff Lake$268K
- Martin BedigianLivingston$240K
- Rameck HuntPlainsboro$217K
- Angel LazoSecaucus$195K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.